StockData
GH Research PLC logo

GH Research PLC (GHRS) stock

GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$17.53−1.03 (-5.55%)

Close on Nov 20, 2026Market cap $1.09BP/E –Yield –

GH Research net income

Net income is the profit left for shareholders after every expense, interest and tax.

GH Research's net income for the twelve months ending Jun 30, 2026 was -$62.27M. For fiscal 2025 it was -$48.26M. The highest annual figure on record is -$310.00K in fiscal 2019.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$48.26M–
FY2024Dec 31, 2024-$38.96M–
FY2023Dec 31, 2023-$35.59M–
FY2022Dec 31, 2022-$22.46M–
FY2021Dec 31, 2021-$9.20M–
FY2020Dec 31, 2020-$446.00K–
FY2019Dec 31, 2019-$310.00K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$15.15M–
Q1 FY2026Mar 31, 2026-$18.97M–
Q4 FY2025Dec 31, 2025-$14.14M–
Q3 FY2025Sep 30, 2025-$14.02M–
Q2 FY2025Jun 30, 2025-$9.29M–
Q1 FY2025Mar 31, 2025-$10.81M–
Q4 FY2024Dec 31, 2024-$8.80M–
Q3 FY2024Sep 30, 2024-$12.11M–
Q2 FY2024Jun 30, 2024-$10.38M–
Q1 FY2024Mar 31, 2024-$7.67M–
Q4 FY2023Dec 31, 2023-$11.27M–
Q3 FY2023Sep 30, 2023-$5.65M–
Q2 FY2023Jun 30, 2023-$7.73M-2414.1%
Q1 FY2023Mar 31, 2023-$10.94M–
Q4 FY2022Dec 31, 2022-$16.59M–
Q3 FY2022Sep 30, 2022-$441.00K–
Q2 FY2022Jun 30, 2022$334.00K–

More GH Research figures

See a number that looks wrong?